Found: 45
Select item for more details and to access through your institution.
Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 9, p. 653, doi. 10.1089/jop.2023.0030
- By:
- Publication type:
- Article
Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Decreased Periodicity of Reactivation Interval in Neovascular Age-Related Macular Degeneration in Patients with a Late First Reactivation After Initial Treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-Term Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characteristics of spontaneous reattachment of rhegmatogenous retinal detachment: optical coherence tomography features and follow-up outcomes.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3703, doi. 10.1007/s00417-021-05304-y
- By:
- Publication type:
- Article
Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 7, p. 1821, doi. 10.1007/s00417-020-05028-5
- By:
- Publication type:
- Article
Long-term natural history of the idiopathic epiretinal membrane in children and young adults.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 10, p. 2141, doi. 10.1007/s00417-020-04787-5
- By:
- Publication type:
- Article
Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 8, p. 1677, doi. 10.1007/s00417-020-04710-y
- By:
- Publication type:
- Article
Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 1, p. 107, doi. 10.1007/s00417-019-04474-0
- By:
- Publication type:
- Article
Focal retinal pigment epithelium atrophy at the location of type 3 neovascularization lesion: a morphologic feature associated with low reactivation rate and favorable prognosis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 8, p. 1661, doi. 10.1007/s00417-019-04373-4
- By:
- Publication type:
- Article
Correction to: Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 6, p. 1183, doi. 10.1007/s00417-019-04306-1
- By:
- Publication type:
- Article
Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 5, p. 891, doi. 10.1007/s00417-018-04228-4
- By:
- Publication type:
- Article
Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2018, v. 256, n. 3, p. 469, doi. 10.1007/s00417-017-3877-5
- By:
- Publication type:
- Article
Short-Term Outcomes of Cataract Surgery in Patients with a History of Central Serous Chorioretinopathy.
- Published in:
- Journal of Ophthalmology, 2021, p. 1, doi. 10.1155/2021/9952050
- By:
- Publication type:
- Article
Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion.
- Published in:
- Journal of Ophthalmology, 2021, p. 1, doi. 10.1155/2021/6635467
- By:
- Publication type:
- Article
Author Correction: Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-57297-8
- By:
- Publication type:
- Article
Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49749-y
- By:
- Publication type:
- Article
Influence of lesion location on lesion reactivation after initial treatment in neovascular age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 11, p. 3139, doi. 10.1007/s00417-023-06144-8
- By:
- Publication type:
- Article
Difference in characteristics and lesion reactivation between type 3 macular neovascularization with and without subretinal fluid at baseline.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 2, p. 401, doi. 10.1007/s00417-022-05833-0
- By:
- Publication type:
- Article
Development of subretinal hemorrhage after treatment discontinuation for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 10, p. 3231, doi. 10.1007/s00417-022-05702-w
- By:
- Publication type:
- Article
Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 3, p. 839, doi. 10.1007/s00417-021-05405-8
- By:
- Publication type:
- Article
Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
- Published in:
- Japanese Journal of Ophthalmology, 2018, v. 62, n. 1, p. 54, doi. 10.1007/s10384-017-0549-2
- By:
- Publication type:
- Article
Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32398-7
- By:
- Publication type:
- Article
Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25860-5
- By:
- Publication type:
- Article
Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18619-5
- By:
- Publication type:
- Article
Incidence of early complications requiring treatment plan changes after vitreoretinal surgery: a single-center study in South Korea.
- Published in:
- BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03030-z
- By:
- Publication type:
- Article
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
- Published in:
- Indian Journal of Ophthalmology, 2015, v. 63, n. 1, p. 25, doi. 10.4103/0301-4738.151460
- By:
- Publication type:
- Article
Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5739, doi. 10.3390/jcm10245739
- By:
- Publication type:
- Article
Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3580, doi. 10.3390/jcm10163580
- By:
- Publication type:
- Article
Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2637, doi. 10.3390/jcm9082637
- By:
- Publication type:
- Article
Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1145, doi. 10.3390/jcm9041145
- By:
- Publication type:
- Article
Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93811-7
- By:
- Publication type:
- Article
Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91589-2
- By:
- Publication type:
- Article
Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome.
- Published in:
- Journal of Ophthalmology, 2018, p. 1, doi. 10.1155/2018/2578349
- By:
- Publication type:
- Article
Cumulative effect of metabolic syndrome on the risk of retinal vein occlusion in young patients: A nationwide population-based study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303871
- By:
- Publication type:
- Article
Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72030-6
- By:
- Publication type:
- Article
Importance of optical coherence tomography raster scans in early detection of active fellow-eye neovascularization in unilateral neovascular age-related macular degeneration.
- Published in:
- BMC Ophthalmology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12886-024-03613-4
- By:
- Publication type:
- Article